Loading clinical trials...
Loading clinical trials...
Phase I Study of Everolimus + Bendamustine in Patients With Relapsed/Refractory Hematological Malignancies
Conditions
Interventions
everolimus
bendamustine hydrochloride
Locations
1
United States
University of California Davis
Sacramento, California, United States
Start Date
October 1, 2014
Primary Completion Date
April 9, 2018
Completion Date
April 9, 2018
Last Updated
January 4, 2019
NCT06859008
NCT02520791
NCT02446457
NCT01815749
NCT03015896
NCT02797470
Lead Sponsor
University of California, Davis
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions